134 related articles for article (PubMed ID: 36066130)
21. Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies.
Wada DA; Law ME; Hsi ED; Dicaudo DJ; Ma L; Lim MS; Souza Ad; Comfere NI; Weenig RH; Macon WR; Erickson LA; Ozsan N; Ansell SM; Dogan A; Feldman AL
Mod Pathol; 2011 Apr; 24(4):596-605. PubMed ID: 21169992
[TBL] [Abstract][Full Text] [Related]
22. The First Case of Gamma-Delta Primary Cutaneous Anaplastic Large Cell Lymphoma?
Taibo A; Cassarino D; Fernandez-Flores A
Am J Dermatopathol; 2022 Oct; 44(10):786-787. PubMed ID: 36122341
[No Abstract] [Full Text] [Related]
23. Targeting Tumor-Infiltrating B Cells in Cutaneous T-Cell Lymphoma.
Theurich S; Schlaak M; Steguweit H; Heukamp LC; Wennhold K; Kurschat P; Rabenhorst A; Hartmann K; Schlösser H; Shimabukuro-Vornhagen A; Holtick U; Hallek M; Stadler R; von Bergwelt-Baildon M
J Clin Oncol; 2016 Apr; 34(12):e110-6. PubMed ID: 25348001
[No Abstract] [Full Text] [Related]
24. Primary cutaneous peripheral T-cell lymphoma with aberrant coexpression of CD20: case report and review of the literature.
Balmer NN; Hughey L; Busam KJ; Reddy V; Andea AA
Am J Dermatopathol; 2009 Apr; 31(2):187-92. PubMed ID: 19318808
[TBL] [Abstract][Full Text] [Related]
25. Large-cell transformation of mycosis fungoides-differential diagnosis with implications for clinical management: a consensus statement of the US Cutaneous Lymphoma Consortium.
Kadin ME; Hughey LC; Wood GS
J Am Acad Dermatol; 2014 Feb; 70(2):374-6. PubMed ID: 24438952
[No Abstract] [Full Text] [Related]
26. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
[TBL] [Abstract][Full Text] [Related]
27. Primary cutaneous CD30 positive T-cell lymphoproliferative disorders with aberrant expression of PAX5: report of three cases.
Hagiwara M; Tomita A; Takata K; Shimoyama Y; Yoshino T; Tomita Y; Nakamura S
Pathol Int; 2012 Apr; 62(4):264-70. PubMed ID: 22449230
[TBL] [Abstract][Full Text] [Related]
28. Primary cutaneous follicle center lymphoma with aberrant CD8 expression.
Lee J; Cohen JA; Wrone DA; Gru AA
J Cutan Pathol; 2022 Apr; 49(4):403-407. PubMed ID: 34797569
[TBL] [Abstract][Full Text] [Related]
29. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
[TBL] [Abstract][Full Text] [Related]
30. Treatment of radiation-relapsing primary cutaneous B-cell lymphoma with an anti-CD20 monoclonal antibody.
Lacouture ME; Baron JM; Jani AB; Laumann AE; Soltani K
Clin Exp Dermatol; 2005 Jan; 30(1):46-8. PubMed ID: 15663503
[TBL] [Abstract][Full Text] [Related]
31. CD20 positive T cell lymphoma: is it a real entity?
Sun T; Akalin A; Rodacker M; Braun T
J Clin Pathol; 2004 Apr; 57(4):442-4. PubMed ID: 15047755
[TBL] [Abstract][Full Text] [Related]
32. Primary cutaneous T-cell-rich B-cell lymphoma in a zosteriform distribution associated with Epstein-Barr virus infection.
Watabe H; Kawakami T; Soma Y; Baba T; Mizoguchi M
J Dermatol; 2002 Nov; 29(11):748-53. PubMed ID: 12484440
[TBL] [Abstract][Full Text] [Related]
33. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
[TBL] [Abstract][Full Text] [Related]
34. CD3-and CD20-negative extramedullary non-Hodgkin leukemia/lymphoma: a histopathological study of 118 cases.
Maeshima AM; Taniguchi H; Hattori D; Sasaki H; Hori Y; Makita S; Iwaki N; Fukuhara S; Munakata W; Suzuki T; Izutsu K
Hum Pathol; 2022 Jun; 124():14-23. PubMed ID: 35307403
[TBL] [Abstract][Full Text] [Related]
35. [CD20-positive T cell lymphoma: clinicopathological features of five cases].
Shao SH; Wang Y; Dai XY; Xiao YJ; Guan JJ; Lin DL; Wang JG; Li YJ; Xing XM; Zhao P
Zhonghua Bing Li Xue Za Zhi; 2020 Oct; 49(10):1021-1026. PubMed ID: 32992416
[No Abstract] [Full Text] [Related]
36. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study.
Oschlies I; Lisfeld J; Lamant L; Nakazawa A; d'Amore ES; Hansson U; Hebeda K; Simonitsch-Klupp I; Maldyk J; Müllauer L; Tinguely M; Stücker M; Ledeley MC; Siebert R; Reiter A; Brugières L; Klapper W; Woessmann W
Haematologica; 2013 Jan; 98(1):50-6. PubMed ID: 22773605
[TBL] [Abstract][Full Text] [Related]
37. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
38. De Novo Unclassifiable CD20-Negative Diffuse Large B-Cell Lymphoma: A Diagnostic and Therapeutic Challenge.
AbdullGaffar B; Seliem RM
Int J Surg Pathol; 2018 May; 26(3):266-270. PubMed ID: 28982264
[TBL] [Abstract][Full Text] [Related]
39. The absence of CD20 messenger RNA in recurrent cutaneous B-cell lymphoma following rituximab therapy.
Rawal YB; Nuovo GJ; Frambach GE; Porcu P; Baiocchi RA; Magro CM
J Cutan Pathol; 2005 Oct; 32(9):616-21. PubMed ID: 16176299
[TBL] [Abstract][Full Text] [Related]
40. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
